Curaleaf (OTCMKTS:CURLF) Stock Moved Down to “Hold” by Zacks Research

Zacks Research cut shares of Curaleaf (OTCMKTS:CURLF) from a strong-buy rating to a hold rating in a report issued on Tuesday,Zacks reports.

CURLF has been the topic of several other research reports. UBS Group set a $6.00 price target on Curaleaf in a research report on Monday, October 5th. Citigroup reaffirmed a “buy” rating on shares of Curaleaf in a research report on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Curaleaf presently has an average rating of “Buy” and a consensus price target of $6.00.

Curaleaf Trading Down 2.9%

Shares of Curaleaf stock opened at $8.56 on Tuesday. Curaleaf has a 1 year low of $5.40 and a 1 year high of $15.15. The company has a debt-to-equity ratio of 1.06, a quick ratio of 0.73 and a current ratio of 1.52. The company has a market capitalization of $2.00 billion, a P/E ratio of -65.84 and a beta of 1.55. The company’s fifty day moving average is $9.91 and its two-hundred day moving average is $8.68.

Curaleaf (OTCMKTS:CURLF) last announced its earnings results on Wednesday, August 5th. The company reported $0.05 EPS for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.25. Curaleaf had a negative net margin of 2.62% and a negative return on equity of 0.88%. The business had revenue of $340.10 million during the quarter, compared to analysts’ expectations of $332.00 million. Analysts forecast that Curaleaf will post 0.01 earnings per share for the current year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, manufactures and sells cannabis products. Through its retail dispensaries and wholesale operations, the company offers flower, pre-rolls, vaporizers, edibles, concentrates, tinctures and other cannabis-derived products for medical and adult-use markets, where permitted by law.

Curaleaf markets products under brands that include Curaleaf, Select and Grassroots. Its business is primarily focused on the United States, where it operates a network of cultivation and processing facilities, dispensaries and distribution operations across multiple state-regulated cannabis markets.